To investigate NEK6 expression levels in end-stage disease, we evaluated NEK6 levels in postmortem motor cortex from C9orf72 patients, healthy controls and non-C9orf72 ALS/FTD patients (Table S4). Here, C9orf72 is linked to amyotrophic lateral sclerosis.